KR101848122B1 - 환자 부분모집단에서의 통풍 치료 방법 - Google Patents
환자 부분모집단에서의 통풍 치료 방법 Download PDFInfo
- Publication number
- KR101848122B1 KR101848122B1 KR1020147015209A KR20147015209A KR101848122B1 KR 101848122 B1 KR101848122 B1 KR 101848122B1 KR 1020147015209 A KR1020147015209 A KR 1020147015209A KR 20147015209 A KR20147015209 A KR 20147015209A KR 101848122 B1 KR101848122 B1 KR 101848122B1
- Authority
- KR
- South Korea
- Prior art keywords
- subject
- uric acid
- gout
- compound
- acid
- Prior art date
Links
- 0 C*c1cc(OC(C(*)=O)c2ccc(*)cc2)ccc1 Chemical compound C*c1cc(OC(C(*)=O)c2ccc(*)cc2)ccc1 0.000 description 2
Images
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
- A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
- A61K31/216—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acids having aromatic rings, e.g. benactizyne, clofibrate
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/12—Drugs for disorders of the urinary system of the kidneys
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/06—Antigout agents, e.g. antihyperuricemic or uricosuric agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
Landscapes
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Engineering & Computer Science (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Urology & Nephrology (AREA)
- Diabetes (AREA)
- Pain & Pain Management (AREA)
- Rheumatology (AREA)
- Physical Education & Sports Medicine (AREA)
- Emergency Medicine (AREA)
- Epidemiology (AREA)
- Hematology (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
PCT/US2011/059425 WO2013066352A1 (en) | 2011-11-04 | 2011-11-04 | Methods for treating gout in patient subpopulations |
Publications (2)
Publication Number | Publication Date |
---|---|
KR20140123927A KR20140123927A (ko) | 2014-10-23 |
KR101848122B1 true KR101848122B1 (ko) | 2018-04-11 |
Family
ID=48192536
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
KR1020147015209A KR101848122B1 (ko) | 2011-11-04 | 2011-11-04 | 환자 부분모집단에서의 통풍 치료 방법 |
Country Status (14)
Country | Link |
---|---|
EP (1) | EP2775835A4 (zh) |
JP (1) | JP6047172B2 (zh) |
KR (1) | KR101848122B1 (zh) |
CN (1) | CN104066323A (zh) |
AU (1) | AU2011380509B2 (zh) |
BR (1) | BR112014010693A2 (zh) |
CA (1) | CA2859689C (zh) |
CL (1) | CL2014001156A1 (zh) |
IL (1) | IL232385A (zh) |
MX (1) | MX354846B (zh) |
NZ (1) | NZ624714A (zh) |
SG (1) | SG11201402027PA (zh) |
WO (1) | WO2013066352A1 (zh) |
ZA (1) | ZA201403574B (zh) |
Families Citing this family (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR20150002799A (ko) * | 2012-04-13 | 2015-01-07 | 사이머베이 쎄라퓨틱스, 인코퍼레이티드 | 할로페네이트 또는 할로펜산 및 소염제를 이용한 통풍 환자에서의 고요산혈증 치료 방법 |
CN104068288B (zh) * | 2014-07-25 | 2016-08-24 | 许伟琦 | 一种防尿路结石的饲料添加剂 |
CN105920022A (zh) * | 2016-05-12 | 2016-09-07 | 成都易创思生物科技有限公司 | 一种抗痛风药物复方制剂 |
JP7086980B2 (ja) * | 2017-10-26 | 2022-06-20 | 大塚製薬株式会社 | イノシトールリン酸含有組成物 |
Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2003501383A (ja) | 1999-06-04 | 2003-01-14 | メタボレックス, インコーポレイテッド | インスリン抵抗性、2型糖尿病、高脂血症および高尿酸血症の処置のための、(−)(3−トリハロメチルフェノキシ)(4−ハロフェニル)酢酸誘導体の使用 |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4250191A (en) * | 1978-11-30 | 1981-02-10 | Edwards K David | Preventing renal failure |
TWI415840B (zh) * | 2007-11-27 | 2013-11-21 | Ardea Biosciences Inc | 新穎化合物、組合物及使用方法 |
-
2011
- 2011-11-04 EP EP11875027.2A patent/EP2775835A4/en not_active Withdrawn
- 2011-11-04 JP JP2014541012A patent/JP6047172B2/ja not_active Expired - Fee Related
- 2011-11-04 WO PCT/US2011/059425 patent/WO2013066352A1/en active Application Filing
- 2011-11-04 KR KR1020147015209A patent/KR101848122B1/ko active IP Right Grant
- 2011-11-04 SG SG11201402027PA patent/SG11201402027PA/en unknown
- 2011-11-04 CN CN201180076189.7A patent/CN104066323A/zh active Pending
- 2011-11-04 BR BR112014010693-2A patent/BR112014010693A2/pt not_active IP Right Cessation
- 2011-11-04 AU AU2011380509A patent/AU2011380509B2/en not_active Ceased
- 2011-11-04 NZ NZ624714A patent/NZ624714A/en not_active IP Right Cessation
- 2011-11-04 MX MX2014005399A patent/MX354846B/es active IP Right Grant
- 2011-11-04 CA CA2859689A patent/CA2859689C/en not_active Expired - Fee Related
-
2014
- 2014-04-30 IL IL232385A patent/IL232385A/en active IP Right Grant
- 2014-05-02 CL CL2014001156A patent/CL2014001156A1/es unknown
- 2014-05-16 ZA ZA2014/03574A patent/ZA201403574B/en unknown
Patent Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2003501383A (ja) | 1999-06-04 | 2003-01-14 | メタボレックス, インコーポレイテッド | インスリン抵抗性、2型糖尿病、高脂血症および高尿酸血症の処置のための、(−)(3−トリハロメチルフェノキシ)(4−ハロフェニル)酢酸誘導体の使用 |
Non-Patent Citations (2)
Title |
---|
Metabolex Appoints Raymond Urbanski M.D., Ph.D. to Position of Chief Medical Officer, PR Newswire(2011.10.20.) |
Metabolex Initiates Phase 2 Trial of Arhalofenate, PR Newswire(2011.05.19.) |
Also Published As
Publication number | Publication date |
---|---|
MX2014005399A (es) | 2015-04-08 |
BR112014010693A2 (pt) | 2020-11-10 |
NZ624714A (en) | 2016-01-29 |
SG11201402027PA (en) | 2014-09-26 |
CA2859689C (en) | 2018-05-22 |
ZA201403574B (en) | 2015-11-25 |
CA2859689A1 (en) | 2013-05-10 |
EP2775835A1 (en) | 2014-09-17 |
MX354846B (es) | 2018-03-22 |
IL232385A (en) | 2017-10-31 |
IL232385A0 (en) | 2014-06-30 |
WO2013066352A1 (en) | 2013-05-10 |
JP6047172B2 (ja) | 2016-12-21 |
KR20140123927A (ko) | 2014-10-23 |
AU2011380509B2 (en) | 2016-05-19 |
EP2775835A4 (en) | 2015-07-29 |
CN104066323A (zh) | 2014-09-24 |
JP2014532759A (ja) | 2014-12-08 |
CL2014001156A1 (es) | 2015-01-16 |
AU2011380509A1 (en) | 2014-05-29 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
KR101848121B1 (ko) | 통풍 발열의 치료법 | |
KR101848122B1 (ko) | 환자 부분모집단에서의 통풍 치료 방법 | |
US9433612B2 (en) | Methods for treating hyperuricemia in patients with gout using halofenate or halofenic acid and a second urate-lowering agent | |
JP6202633B2 (ja) | ハロフェナートまたはハロフェン酸および第2の尿酸低下薬を用いる痛風に罹っている患者の高尿酸血症の治療方法 | |
JP6368756B2 (ja) | ハロフェナートまたはハロフェン酸および第2の尿酸低下薬を用いる痛風に罹っている患者の高尿酸血症の治療方法 | |
AU2013245675B2 (en) | Method for treating hyperuricemia in patients with gout using halofenate or halofenic acid and an anti-inflammatory agent | |
JP6192142B2 (ja) | 痛風発赤の治療方法 | |
US20130302305A1 (en) | Methods for Treating Gout in Patients Subpopulations |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
A201 | Request for examination | ||
N231 | Notification of change of applicant | ||
E902 | Notification of reason for refusal | ||
E701 | Decision to grant or registration of patent right | ||
GRNT | Written decision to grant |